| Mechanism of fat taste perception: Association with diet and obesity D Liu, N Archer, K Duesing, G Hannan, R Keast Progress in lipid research 63, 41-49, 2016 | 167 | 2016 |
| MiR-612 regulates invadopodia of hepatocellular carcinoma by HADHA-mediated lipid reprogramming Y Liu, LL Lu, D Wen, DL Liu, LL Dong, DM Gao, XY Bian, J Zhou, J Fan, ... Journal of hematology & oncology 13, 1-19, 2020 | 61 | 2020 |
| miR-612 suppresses stem cell-like property of hepatocellular carcinoma cells by modulating Sp1/Nanog signaling Y Liu, DL Liu, LL Dong, D Wen, DM Shi, J Zhou, J Fan, WZ Wu Cell death & disease 7 (9), e2377-e2377, 2016 | 50 | 2016 |
| miR-17-5p and miR-20a-5p suppress postoperative metastasis of hepatocellular carcinoma via blocking HGF/ERBB3-NF-κB positive feedback loop DL Liu, LL Lu, LL Dong, Y Liu, XY Bian, BF Lian, L Xie, D Wen, DM Gao, ... Theranostics 10 (8), 3668, 2020 | 46 | 2020 |
| Expression of the candidate fat taste receptors in human fungiform papillae and the association with fat taste function D Liu, A Costanzo, MDM Evans, NS Archer, C Nowson, K Duesing, ... British journal of nutrition 120 (1), 64-73, 2018 | 33 | 2018 |
| A low-fat diet up-regulates expression of fatty acid taste receptor gene FFAR4 in fungiform papillae in humans: a co-twin randomised controlled trial A Costanzo, D Liu, C Nowson, K Duesing, N Archer, S Bowe, R Keast British journal of nutrition 122 (11), 1212-1220, 2019 | 28 | 2019 |
| A c-Myc/miR-17-5p feedback loop regulates metastasis and invasion of hepatocellular carcinoma D Liu, L Dong, Y Liu, D Wen, D Gao, H Sun, J Fan, W Wu Tumor Biology 37, 5039-5047, 2016 | 25 | 2016 |
| ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target D Liu, K Gunther, LA Enriquez, B Daniels, TA O’Mara, K Tang, AB Spurdle, ... Scientific Reports 10 (1), 13906, 2020 | 22 | 2020 |
| Outcomes and patterns of secondary relapse in platinum-sensitive ovarian cancer: implications for tertiary cytoreductive surgery J Tang, DL Liu, S Shu, WJ Tian, Y Liu, RY Zang European Journal of Surgical Oncology (EJSO) 39 (7), 786-791, 2013 | 21 | 2013 |
| A comparison of collection techniques for gene expression analysis of human oral taste tissue NS Archer, D Liu, J Shaw, G Hannan, K Duesing, R Keast PloS one 11 (3), e0152157, 2016 | 19 | 2016 |
| Cell-free DNA is abundant in ascites and represents a liquid biopsy of ovarian cancer B Werner, N Yuwono, J Duggan, D Liu, C David, S Srirangan, P Provan, ... Gynecologic Oncology 162 (3), 720-727, 2021 | 18 | 2021 |
| SPP1 is a prognostic related biomarker and correlated with tumor-infiltrating immune cells in ovarian cancer W Gao, D Liu, H Sun, Z Shao, P Shi, T Li, S Yin, T Zhu BMC cancer 22 (1), 1367, 2022 | 13 | 2022 |
| An organotypic model of high-grade serous ovarian cancer to test the anti-metastatic potential of ROR2 targeted Polyion complex nanoparticles N Joshi, D Liu, KA Dickson, DJ Marsh, CE Ford, MH Stenzel Journal of Materials Chemistry B 9 (44), 9123-9135, 2021 | 13 | 2021 |
| The anti-ROR1 monoclonal antibody zilovertamab inhibits the proliferation of ovarian and endometrial cancer cells D Liu, GF Kaufmann, JB Breitmeyer, KA Dickson, DJ Marsh, CE Ford Pharmaceutics 14 (4), 837, 2022 | 9 | 2022 |
| ROR1 and ROR2 expression in pancreatic cancer D Liu, G Sharbeen, P Phillips, CE Ford BMC cancer 21, 1-11, 2021 | 8 | 2021 |
| ROR2 is epigenetically regulated in endometrial cancer D Liu, L Enriquez, CE Ford Cancers 13 (3), 383, 2021 | 6 | 2021 |
| Model Parameter identification using 2D vs 3D experimental data: a comparative analysis M Cortesi, D Liu, C Yee, DJ Marsh, CE Ford BioRxiv, 2023.05. 17.541071, 2023 | 1 | 2023 |
| Abstract B014: Patient-derived organoid models for drug screening in molecular subtypes of endometrial cancer D Liu, E Powell, KM Wan, R Athavale, C Loo, CE Ford Clinical Cancer Research 30 (5_Supplement), B014-B014, 2024 | | 2024 |
| Author Correction: A comparative analysis of 2D and 3D experimental data for the identification of the parameters of computational models M Cortesi, D Liu, C Yee, DJ Marsh, CE Ford Scientific Reports 14, 2024 | | 2024 |
| Drug repurposing screen targeting PARP identifies cytotoxic activity of efavirenz in high-grade serous ovarian cancer B Matthews, M Wong-Brown, D Liu, C Yee, K Dickson, J Schneider, ... | | 2023 |
